Evidence
World J Gastroenterol. 2024 May 28;30(20):2629-2632. doi: 10.3748/wjg.v30.i20.2629.
ABSTRACT
This editorial delves into the research article by Zeng et al published in the latest issue of World Journal of Gastroenterology. The manuscript contributes significantly to addressing the global health issue of nonalcoholic fatty liver disease (NAFLD) by introducing and validating the Exercise and Diet Adherence Scale (EDAS). The article effectively conveys the importance of the study, highlighting the prevalence of NAFLD, the lack of approved drugs for its treatment, and the crucial role of lifestyle correction. The use of the Delphi method for scale deve-lopment and the subsequent evaluation of its reliability add scientific rigor to the methodology. The results demonstrate that the scale is correlated with key lifestyle indicators, which makes it a promising tool for assessing patient adherence to interventions. The identification of specific score thresholds for predicting adherence to daily calorie intake and exercise adds practical value to the scale. The differentiation among scores indicative of good, average, and poor adherence enhances its clinical applicability. In conclusion, the manuscript introduces EDAS, a valuable instrument that can contribute substantially to the field of NAFLD research and clinical practice.
PMID:38855158 | PMC:PMC11154672 | DOI:10.3748/wjg.v30.i20.2629
Estimated reading time: 4 minute(s)
Latest: Psychiatryai.com #RAISR4D Evidence
Cool Evidence: Engaging Young People and Students in Real-World Evidence
Real-Time Evidence Search [Psychiatry]
AI Research
Validation of adherence prediction system for lifestyle interventions in nonalcoholic fatty liver disease
🌐 90 Days
AI Virtual Reality Related Evidence Matrix
- Impact of lifestyle interventions on pathogenesis of nonalcoholic fatty liver disease
- Establishment and validation of an adherence prediction system for lifestyle interventions in non-alcoholic fatty liver disease
- Muscle strength and non-alcoholic fatty liver disease/metabolic-associated fatty liver disease
- Fecal microbiota transplantation for treatment of non-alcoholic fatty liver disease: Mechanism, clinical evidence, and prospect
- Metabolic dysfunction-associated fatty liver disease and low muscle strength: A comment
- Interplay between metabolic dysfunction-associated fatty liver disease and renal function: An intriguing pediatric perspective
- Global perspective on nonalcoholic fatty liver disease and nonalcoholic steatohepatitis - prevalence, clinical impact, economic implications and management strategies
- Pathophysiological Features of Rat Models of Nonalcoholic Fatty Liver Disease/Nonalcoholic Steatohepatitis
- Natural compounds proposed for the management of non-alcoholic fatty liver disease
- The Role of PNPLA3_rs738409 Gene Variant, Lifestyle Factors, and Bioactive Compounds in Nonalcoholic Fatty Liver Disease: A Population-Based and Molecular Approach towards Healthy Nutrition
- Serum Vitamin D Level in Overweight Individuals and Its Correlation With the Incidence of Non-alcoholic Fatty Liver Disease
- Unraveling the relationship between histone methylation and nonalcoholic fatty liver disease
- Cultivated Enterococcus faecium B6 from children with obesity promotes nonalcoholic fatty liver disease by the bioactive metabolite tyramine
- The association of Neuromedin U levels and non-alcoholic fatty liver disease: A comparative analysis
- Six-gene prognostic signature for non-alcoholic fatty liver disease susceptibility using machine learning
- Roles and Mechanisms of Choline Metabolism in Nonalcoholic Fatty Liver Disease and Cancers
- Lian-Mei-Yin formula alleviates diet-induced hepatic steatosis by suppressing Yap1/FOXM1 pathway-dependent lipid synthesis
- The Influence of Emodin Succinyl Ethyl Ester on Non-Alcoholic Steatohepatitis Induced by a Diet High in Fructose, Cholesterol, and Fat in Mice
- The gut-liver axis in fatty liver disease: role played by natural products
- Semaglutide combined with empagliflozin vs. monotherapy for non-alcoholic fatty liver disease in type 2 diabetes: Study protocol for a randomized clinical trial
- Prevalence of nonalcoholic fatty liver disease and liver cirrhosis in Chinese adults with type 2 diabetes mellitus
- Impact of Transgenerational Nutrition on Nonalcoholic Fatty Liver Disease Development: Interplay between Gut Microbiota, Epigenetics and Immunity
- THE GLOBAL EPIDEMIOLOGY OF NON-ALCOHOLIC FATTY LIVER DISEASE AND NON-ALCOHOLIC STEATOHEPATITIS AMONG PATIENTS WITH TYPE 2 DIABETES
- Association between Baltic sea diet and healthy Nordic diet index with risk of non-alcoholic fatty liver disease: a case-control study
- Complex dichotomous links of nonalcoholic fatty liver disease and inflammatory bowel disease: exploring risks, mechanisms, and management modalities
- Intestinal Barrier Dysfunction and Gut Microbiota in Non-Alcoholic Fatty Liver Disease: Assessment, Mechanisms, and Therapeutic Considerations
- How to Enhance Adherence in Patients with Nonalcoholic Fatty Liver Disease: A Thought-Provoking Issue
- Management of Cardiovascular Risk in the Non-alcoholic Fatty Liver Disease Setting
- Changes in the terminology and diagnostic criteria of non-alcoholic fatty liver disease: Implications and opportunities
- Huanglian-Hongqu herb pair improves nonalcoholic fatty liver disease via NF-κB/NLRP3 pathway in mice: network pharmacology, molecular docking and experimental validation
- Mitochondrial ACSS1-K635 acetylation knock-in mice exhibit altered metabolism, cell senescence, and nonalcoholic fatty liver disease
- 4,4-Diallyl curcumin bis(2,2-hydroxymethyl)propanoate ameliorates nonalcoholic steatohepatitis in methionine-choline-deficient diet and Western diet mouse models
- Hypercaloric low-carbohydrate high-fat diet protects against the development of nonalcoholic fatty liver disease in obese mice in contrast to isocaloric Western diet
- Exploring the role of genetic variations in NAFLD: implications for disease pathogenesis and precision medicine approaches
- Prevalence and risk of nonalcoholic fatty liver disease among adult psoriatic patients: A systematic review, meta-analysis, and trial sequential analysis
- Metabolic Dysfunction-associated Fatty Liver Disease: An Urgent Call for Global Action
- Clinical and patient-reported outcomes in patients with chronic hepatitis B and C and non-alcoholic fatty liver disease from real-world practices in Saudi Arabia, Turkey and Egypt
- Clinical and patient-reported outcomes in patients with chronic hepatitis B and C and non-alcoholic fatty liver disease from real-world practices in Saudi Arabia, Turkey and Egypt
- Nonalcoholic Fatty Liver Disease and Ethnicity: Lessons Learned from the Arab Population in Israel
- Association between sleep duration and a new onset of nonalcoholic fatty liver disease
- Novel subtype of obesity influencing the outcomes of sleeve gastrectomy: Familial aggregation of obesity
- Proteome-wide Mendelian randomization identifies potential therapeutic targets for nonalcoholic fatty liver diseases
- Nonalcoholic steatohepatitis: A comprehensive updated review of risk factors, symptoms, and treatment
- Asprosin aggravates nonalcoholic fatty liver disease via inflammation and lipid metabolic disturbance mediated by reactive oxygen species
- A Systematic Review of Statins for the Treatment of Nonalcoholic Steatohepatitis: Safety, Efficacy, and Mechanism of Action
- Advances in management of metabolic dysfunction-associated steatotic liver disease: from mechanisms to therapeutics
- Effects of low fat diet on inflammatory parameters in individuals with obesity/overweight and non-alcoholic fatty liver disease: A cross-sectional study
- The therapeutic effect of alcoholic extract of Fumaria parviflora on high-fat diet-induced nonalcoholic fatty liver in rats: an animal experiment
- Exploring the interconnected between type 2 diabetes mellitus and nonalcoholic fatty liver disease: Genetic correlation and Mendelian randomization analysis
- Genetically predicted fatty liver disease and risk of psychiatric disorders: A mendelian randomization study
- Healthy Lifestyle and the Risk of Metabolic Dysfunction-Associated Fatty Liver Disease: A Large Prospective Cohort Study
- Supplementation of Micro- and Macronutrients-A Role of Nutritional Status in Non-Alcoholic Fatty Liver Disease
- Roflumilast ameliorates GAN diet-induced non-alcoholic fatty liver disease by reducing hepatic steatosis and fibrosis in ob/ob mice
- A novel bellidifolin intervention mitigates nonalcoholic fatty liver disease-like changes induced by bisphenol F
- Non-alcoholic fatty liver disease and sleep disorders
- Non-alcoholic fatty liver disease and sleep disorders
- Research progress on the mechanism of action of heme oxygenase-1 regulating ferroptosis in non-alcoholic fatty liver disease
- Emerging roles of RNA-binding proteins in fatty liver disease
- Prevalence and outcome of sarcopenia in non-alcoholic fatty liver disease
- Progress and hotspot of diet or exercise therapy in the treatment of non-alcoholic fatty liver disease
- Assessing Causal Relationships Between Periodontitis and Non-alcoholic Fatty Liver Disease: A Two-Sample Bidirectional Mendelian Randomisation Study
- Influence of nonalcoholic fatty liver disease severity on carotid adventitial vasa vasorum
- Beneficial Effects of Capybara Oil Supplementation on Steatosis and Liver Apoptosis in Obese Mice
- Non-invasive Scores and Serum Biomarkers for Fatty Liver in the Era of Metabolic Dysfunction-associated Steatotic Liver Disease (MASLD): A Comprehensive Review From NAFLD to MAFLD and MASLD
Evidence Blueprint
Validation of adherence prediction system for lifestyle interventions in nonalcoholic fatty liver disease
☊ AI-Driven Related Evidence Nodes
(recent articles with at least 5 words in title)
More Evidence
Validation of adherence prediction system for lifestyle interventions in nonalcoholic fatty liver disease
🌐 365 Days
AI Virtual Reality Related Evidence Matrix
- Impact of lifestyle interventions on pathogenesis of nonalcoholic fatty liver disease
- Establishment and validation of an adherence prediction system for lifestyle interventions in non-alcoholic fatty liver disease
- Muscle strength and non-alcoholic fatty liver disease/metabolic-associated fatty liver disease
- The therapeutic mechanisms and beneficial effects of ursodeoxycholic acid in the treatment of nonalcoholic fatty liver disease: a systematic review
- Fecal microbiota transplantation for treatment of non-alcoholic fatty liver disease: Mechanism, clinical evidence, and prospect
- Metabolic dysfunction-associated fatty liver disease and low muscle strength: A comment
- Portal hypertension in patients with nonalcoholic fatty liver disease: Current knowledge and challenges
- Interplay between metabolic dysfunction-associated fatty liver disease and renal function: An intriguing pediatric perspective
- Enhanced non-alcoholic fatty liver detection: Computed tomography scan image analysis and noise reduction with morphological dilation
- Circulating microRNA expression and nonalcoholic fatty liver disease in adolescents with severe obesity
- Non-alcoholic fatty liver disease: Immunological mechanisms and current treatments
- Diet and non-alcoholic fatty liver disease, a short narrative review
- Global perspective on nonalcoholic fatty liver disease and nonalcoholic steatohepatitis - prevalence, clinical impact, economic implications and management strategies
- Pathophysiological Features of Rat Models of Nonalcoholic Fatty Liver Disease/Nonalcoholic Steatohepatitis
- Liver health and the interplay between obesity, alcohol and bariatric surgery
- Behaviour regulation and the role of mental health in non-alcoholic fatty liver disease
- SGLT-2 Inhibitors for Non-Alcoholic Fatty Liver Disease: A Review
- Research progress on the histological scoring system for nonalcoholic fatty liver disease
- Natural compounds proposed for the management of non-alcoholic fatty liver disease
- Immunomodulation in non-alcoholic fatty liver disease: exploring mechanisms and applications
- Adherence to healthy lifestyle was associated with an attenuation of the risk of chronic kidney disease from metabolic dysfunction-associated fatty liver disease: Results from two prospective cohorts
- What are the common downstream molecular events between alcoholic and nonalcoholic fatty liver?
- What are the common downstream molecular events between alcoholic and nonalcoholic fatty liver?
- Macrophage heterogeneity role in NAFLD and NASH disease progression
- Hepatocellular and extrahepatic cancer risk in people with non-alcoholic fatty liver disease
- Akkermansia muciniphila - a Potential Next-generation Probiotic for Non-alcoholic Fatty Liver Disease
- Lipophagy: A potential therapeutic target for nonalcoholic and alcoholic fatty liver disease
- Progress in the Treatment of Metabolic-Related Fatty Liver Disease
- The Role of PNPLA3_rs738409 Gene Variant, Lifestyle Factors, and Bioactive Compounds in Nonalcoholic Fatty Liver Disease: A Population-Based and Molecular Approach towards Healthy Nutrition
- Autophagy and the unfolded protein response shape the non-alcoholic fatty liver landscape: decoding the labyrinth
- Serum Vitamin D Level in Overweight Individuals and Its Correlation With the Incidence of Non-alcoholic Fatty Liver Disease
- Non-alcoholic fatty liver disease and periodontal disease: A systematic review and meta-analysis of cross-sectional studies
- Immunology of gut microbiome and liver in non-alcoholic fatty liver disease (NAFLD): mechanisms, bacteria, and novel therapeutic targets
- Insulin resistance and adipose tissue interactions as the cornerstone of metabolic (dysfunction)-associated fatty liver disease pathogenesis
- Mortality from chronic liver disease: Recent trends and impact of the COVID-19 pandemic
- Unraveling the relationship between histone methylation and nonalcoholic fatty liver disease
- Nonalcoholic Fatty Liver Disease as a Systemic Disease and the Need for Multidisciplinary Care
- Cultivated Enterococcus faecium B6 from children with obesity promotes nonalcoholic fatty liver disease by the bioactive metabolite tyramine
- Effect of the nomenclature of non-alcoholic fatty liver disease on diagnosis and treatment of fatty liver disease concomitant with other liver diseases
- The association of Neuromedin U levels and non-alcoholic fatty liver disease: A comparative analysis
- Six-gene prognostic signature for non-alcoholic fatty liver disease susceptibility using machine learning
- Nonalcoholic Fatty Liver Disease and Continuous Metabolic Syndrome in Adolescents with Overweight/Obesity
- Efficacy and safety of semaglutide in non-alcoholic fatty liver disease
- Roles and Mechanisms of Choline Metabolism in Nonalcoholic Fatty Liver Disease and Cancers
- Lian-Mei-Yin formula alleviates diet-induced hepatic steatosis by suppressing Yap1/FOXM1 pathway-dependent lipid synthesis
- The Influence of Emodin Succinyl Ethyl Ester on Non-Alcoholic Steatohepatitis Induced by a Diet High in Fructose, Cholesterol, and Fat in Mice
- Correlation of Nonalcoholic Fatty Liver Disease with Dietary Folate and Serum Folate in U.S. Adults: Cross-Sectional Analyses from National Health and Nutrition Examination Survey 2009-2018
- Atorvastatin on Treatment of Nonalcoholic Fatty Liver Disease Patients
- The gut-liver axis in fatty liver disease: role played by natural products
- Therapeutic Approaches for Nonalcoholic Fatty Liver Disease: Established Targets and Drugs
- Development of a prediction model for predicting the prevalence of nonalcoholic fatty liver disease in Chinese nurses: the first-year follow data of a web-based ambispective cohort study
- Identification and validation of cuproptosis-related molecular clusters in non-alcoholic fatty liver disease
- From complement to complosome in non-alcoholic fatty liver disease: When location matters
- Dietary strategies in non-alcoholic fatty liver disease patients: From evidence to daily clinical practice, a systematic review
- The relationship between alcohol consumption and chronic kidney disease in patients with nonalcoholic fatty liver disease
- Therapeutic management of metabolic dysfunction associated steatotic liver disease
- F-box only protein 2 exacerbates non-alcoholic fatty liver disease by targeting the hydroxyl CoA dehydrogenase alpha subunit
- Effect of exercise and pharmacotherapy on non-alcoholic fatty liver disease
- Clinical Management of Non-alcoholic Steatohepatitis and the Role of the Cardiologist
- The correlation between NAFLD and serum uric acid to serum creatinine ratio
- Glycemic Control Is Associated with Histological Findings of Nonalcoholic Fatty Liver Disease
- Semaglutide combined with empagliflozin vs. monotherapy for non-alcoholic fatty liver disease in type 2 diabetes: Study protocol for a randomized clinical trial
- A global survey of health care workers' awareness of non-alcoholic fatty liver disease: The AwareNASH survey
- Various types of fasting diet and possible benefits in nonalcoholic fatty liver: Mechanism of actions and literature update